Kate Haviland
2016
In 2016, Kate Haviland earned a total compensation of $1.6M as Chief Business Officer at Blueprint Medicines.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $130,937 |
| Option Awards | $1,092,040 |
| Salary | $338,692 |
| Other | $7,950 |
| Total | $1,644,619 |
Haviland received $1.1M in option awards, accounting for 66% of the total pay in 2016.
Haviland also received $75K in bonus, $130.9K in non-equity incentive plan, $338.7K in salary and $8K in other compensation.
Rankings
In 2016, Kate Haviland's compensation ranked 5,818th out of 14,075 executives tracked by ExecPay. In other words, Haviland earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,818 out of 14,075 | 59th |
Division Manufacturing | 2,111 out of 5,489 | 62nd |
Major group Chemicals And Allied Products | 688 out of 1,895 | 64th |
Industry group Drugs | 517 out of 1,538 | 66th |
Industry Pharmaceutical Preparations | 411 out of 1,176 | 65th |
Source: SEC filing on April 27, 2018.
Haviland's colleagues
We found five more compensation records of executives who worked with Kate Haviland at Blueprint Medicines in 2016.
2016
Marion Dorsch
Blueprint Medicines
Chief Scientific Officer
2016
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2016
Tracey McCain
Blueprint Medicines
Chief Legal Officer
2016
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2016
Michael Landsittel
Blueprint Medicines